跳至主要内容
临床试验/2024-514743-28-00
2024-514743-28-00招募中2 期

GeranylGeranylAcetone as prevention for postoperative Atrial Fibrillation (GENIALITY)

Stichting Amsterdam UMC1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2024年9月30日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
146
试验地点
1
主要终点
Assessment of Postoperative atrial fibrillation incidence, by Holter monitoring

研究概览

简要总结

To prevent incidence of postoperative atrial fibrillation on patients undergoing cardiothoracic surgery

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • Aged between 18 and 80 years old
  • Elected for cardiothoracic surgery for mitral valve stenosis or regurgitation, and/or aortic valve stenosis or regurgitation, and/or coronary artery disease

排除标准

  • Documented history of AF
  • Not able to undergo the complete study protocol
  • Previous cardiothoracic surgery
  • Doubt about compliance
  • Pre-menopausal women who are nursing, pregnant, or of child-bearing potential
  • Chronic malabsorption
  • Any documented or suspected malignancy or history of malignancy within 1 year prior to screening, except appropriate treated basal cell carcinoma or in situ carcinoma of the cervix
  • Currently enrolled in another drug trial

结局指标

主要结局

Assessment of Postoperative atrial fibrillation incidence, by Holter monitoring

Assessment of Postoperative atrial fibrillation incidence, by Holter monitoring

次要结局

  • The secondary trial endpoints are assessments of activation of HSPs by biochemical analysis and microscopic imaging; in blood, atrial tissue and epicardial adipose tissue

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Principal Investigator

Scientific

Stichting Amsterdam UMC

研究点 (1)

Loading locations...

相似试验